Literature DB >> 9330687

Structure of CD26 (dipeptidyl peptidase IV) and function in human T cell activation.

M Hegen1, J Kameoka, R P Dong, C Morimoto, S F Schlossman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9330687     DOI： 10.1007/978-1-4757-9613-1_15

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  5 in total

1.  Inhibition of dipeptidyl peptidase IV by fluoroolefin-containing N-peptidyl-O-hydroxylamine peptidomimetics.

Authors:  J Lin; P J Toscano; J T Welch
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

2.  Mice lacking dipeptidyl peptidase IV are protected against obesity and insulin resistance.

Authors:  Stacey L Conarello; Zhihua Li; John Ronan; Ranabir Sinha Roy; Lan Zhu; Guoqiang Jiang; Franklin Liu; John Woods; Emanuel Zycband; David E Moller; Nancy A Thornberry; Bei B Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-14       Impact factor: 11.205

3.  Dipeptidyl peptidase IV on activated T cells as a target molecule for therapy of rheumatoid arthritis.

Authors:  Y N Williams; H Baba; S Hayashi; H Ikai; T Sugita; S Tanaka; N Miyasaka; T Kubota
Journal:  Clin Exp Immunol       Date:  2003-01       Impact factor: 4.330

4.  Crystal structure of human dipeptidyl peptidase IV in complex with a decapeptide reveals details on substrate specificity and tetrahedral intermediate formation.

Authors:  Kathleen Aertgeerts; Sheng Ye; Mike G Tennant; Michelle L Kraus; Joe Rogers; Bi-Ching Sang; Robert J Skene; David R Webb; G Sridhar Prasad
Journal:  Protein Sci       Date:  2004-01-10       Impact factor: 6.725

5.  Beneficial endocrine but adverse exocrine effects of sitagliptin in the human islet amyloid polypeptide transgenic rat model of type 2 diabetes: interactions with metformin.

Authors:  Aleksey V Matveyenko; Sarah Dry; Heather I Cox; Artemis Moshtaghian; Tatyana Gurlo; Ryan Galasso; Alexandra E Butler; Peter C Butler
Journal:  Diabetes       Date:  2009-04-29       Impact factor: 9.461
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.